Chevron Left
Retour à Développement de médicaments

Avis et commentaires pour d'étudiants pour Développement de médicaments par Université de Californie à San Diego

1,839 évaluations
386 avis

À propos du cours

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (, Drug Development and Drug Commercialization ( We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Meilleurs avis

15 oct. 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

24 mai 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.\n\nThank you!

Filtrer par :

301 - 325 sur 385 Avis pour Développement de médicaments

par Komal S

6 juin 2020

Very informative content with lot of information about working of pharmaceutical companies during development of drugs.

par Murali D

9 juil. 2020

The course is very good and gives an overview on clinical studies phase-1 -4. I enjoyed the lectures in this course.

par Muhamad A B A B

8 juil. 2020

Quite difficult to grasp for a newbie. Presentation slides are a bit boring and at certain point, difficult to read.

par Sanjida R M

15 mars 2021

This course is very informative . I have learnt in details about IND, IRB review, about drug commercialization.


30 juil. 2019

Very easy to follow, fun, informal. Downside: speakers often talk in incomplete sentences, use inaudible terms.

par Claudia S

3 oct. 2021

t​he course gives a good overview of the approval process of drug products, however it is a bit outdated

par B M T I

4 juin 2020

This course was really helpful to me.It helps me to know many unknown things.It was really good.Thanks.

par N. F

19 juin 2019

Very informative and useful course. Thank you very much to everyone who helped this work come to light

par Anand A

21 juil. 2020

very good information provided in this videos by eminent people Thanks for this who has provided it.

par James D

15 janv. 2019

Great course, but some of the information is becoming outdated due to the course being from 2013

par Lavanya

25 févr. 2020

Excellent course material could understand the entire scenario of clinical trial as a beginner

par Jan B

26 févr. 2019

An interesting introduction. It is more of an overview than an actual course. Would do again.


7 mai 2020

happy to learn new things regarding the drug development . thqnks for this great opportunity

par Nadia C

30 janv. 2020

some of the things was a little bit old - But i liked the content and the concepts

par Aderbal A

18 avr. 2021

the course is good, but classes are old and outdated. Many classes are lectures.

par Yury K

2 déc. 2019

Need to update the lectures to reflect rapidly changing regulatory issues

par Hiep X N

5 août 2017

Informative course, instructors have a great deal of industry experiences

par abbas a

28 mai 2020

It was very helpful to me,and I learned much better in this quarantine.

par Vindhya S R

6 nov. 2020

It was indeed a great course. It was quite informative. Thank you!

par Morongwa

26 mars 2020

Thoroughly enjoyed this. Could do with an updating of materials.

par Ugbosu F O

27 mai 2021

It was at first looking boring but i ended up having a nice time


10 sept. 2020

Me ha parecido muy interesante el mundo farmacéutico-industrial.

par shubham b

21 sept. 2021

i have learned all the phases in brief thanks to coursera .

par Matthew K

3 août 2017

Good primer on Drug Development albeit very high level.

par Avishek S

27 août 2020

It can be more arranged and in detail.

but pretty good.